Company Overview
| Stock Name | Ump |
|---|---|
| Stock Code | 00722 |
| Company Full Name | To be extracted |
| Industry | Healthcare |
| Principal Activities | 本集團是香港前列的企業醫療保健解決方案提供者,透過UMP醫務中心及聯屬診所組成的網絡,向合約客戶及自費患者提供全面的醫療保健服務,包括醫療服務、牙科服務及輔助服務。 |
| Listing Date | 2015-11-27 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港德輔道中71號永安集團大廈27樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | www.ump.com.hk |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | Mechanism A |
|---|---|
| Offer Price | HK$ 2.06 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | 2015-11-17 to 2015-11-20 |
| Global Offering Shares | 184,000,000 shares |
| HK Public Offer Shares (Initial) | 18,400,000 shares (10.0%) |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | 165,600,000 shares (90.0%) |
| Offer Ratio | ~10.0% |
| Total Shares Post-IPO | 736,000,000 shares |
| Greenshoe (Over-allotment Option) | No |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | Yes |
| Total Global Offering Size | HK$ 379,040,000 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 341M |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +2654% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | 900.0百万港元 |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | 盈利约40.9百万港元 |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | 约370.4百万港元 |
Financial Data
Unit:
RMB
Income Statement
| Item | 2013-06 | 2014-06 | 2015-06 |
|---|---|---|---|
| Revenue | 4,642,356 | 16,760,656 | 24,411,458 |
| Cost of sales | -138,617 | -279,498 | |
| Other income and gains, net | 56,269 | 60,865 | 61,749 |
| Profit before tax | -152,773 | 4,504,952 | 5,409,586 |
| Income tax expense | -75,347 | -393,681 | -1,312,246 |
| Profit for the year | -228,120 | 4,111,271 | 4,097,340 |
Balance Sheet
| Item | 2013-06 | 2014-06 | 2015-06 |
|---|---|---|---|
| Cash and cash equivalents | 2,171,885 | 6,696,131 | 10,274,553 |
| Trade and bills receivables | 366,803 | 264,830 | 173,749 |
| Inventories | 1,616 | 113,828 | 120,671 |
| Total current assets | 7,183,007 | 12,621,897 | 15,175,559 |
| Total current liabilities | 4,767,303 | 10,210,276 | 8,295,528 |
| Total equity | 5,605,782 | 9,717,053 | 13,814,393 |
Cash Flow Statement
| Item | 2013-06 | 2014-06 | 2015-06 |
|---|---|---|---|
| Net cash from operating activities | 1,701,677 | 4,381,778 | 5,789,205 |
| Net cash from investing activities | -2,944,114 | -209,283 | -703,219 |
| Net cash from financing activities | 1,674,533 | 351,751 | -1,507,564 |
| Net increase in cash | 432,096 | 4,524,246 | 3,578,422 |
| Depreciation of PP&E | 228,494 | 816,878 | 1,057,196 |
| Purchase of PP&E | -2,950,383 | -1,204,818 | -752,276 |
Income Statement
Balance Sheet
Cash Flow Statement
Source: Accountants' Report and Audited Consolidated Financial Statements
| First Day Close | HK$ 1.93 |
|---|---|
| First Day Open | HK$ 1.81 |
| First Day Change | -6.31% |
| First Day Volume | 67576000.0 |
| First Day Turnover | 127797000.0 |
| Use of Proceeds | 1、約200.2百萬港元(約60.0%)將用于集團在中國的擴展;
2、約100.1百萬港元(約30.0%)將用于擴大本集團在香港的業務;
3、剩余所得款項約33.4百萬港元(約10.0%)將用作本集團的營運資金及其他一般企業用途。 |
Underwriting Syndicate
Sole Sponsor (1)
J.P. Morgan Securities (Far East) Limited CE AAB026
Overall Coordinators (1)
J.P. Morgan Securities (Asia Pacific) Limited CE AAJ321
Joint Bookrunners (2)
Joint Lead Managers (2)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | 孫耀江 | — |
| Company Secretary | 馬凱雲 | — |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 控股股東孫耀江醫生透過East Majestic及EM Team合共持有約33.12%股權;周大福企業透過Healthcare Ventures持股15%;鳳凰醫療透過Pinyu持股15%。 |
|---|




